Suchergebnisse - "Moore, Kathleen N"

PubPharm (274)

1

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary : An NRG oncology study GY016

enthalten in: Gynecologic oncology | 2024

von Gien, L. | Enserro, D. | Block, M. | +13

2

Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer

enthalten in: Gynecologic oncology | 2024

von Richardson, D. | Moore, K. | Vergote, I. | +10

3

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

enthalten in: The New England journal of medicine | 2023

von Moore, K. | Angelergues, A. | Konecny, G. | +128

4

Cannabis use among adults undergoing cancer treatment

enthalten in: Cancer | 2023

von Azizoddin, D. | Cohn, A. | Ulahannan, S. | +7

5

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Grisham, R. | Vergote, I. | Banerjee, S. | +27

6

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma

enthalten in: Molecular cancer therapeutics | 2023

von Hamilton, E. | Wang, J. | Oza, A. | +14

7

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

enthalten in: Gynecologic oncology | 2023

von Pignata, S. | Bookman, M. | Sehouli, J. | +22

8

Low-grade serous ovarian cancer : expert consensus report on the state of the science

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Grisham, R. | Slomovitz, B. | Andrews, N. | +16

CommentIn: Int J Gynecol Cancer. 2023 Sep 4;33(9):1345-1346. - PMID 37666542

9

ARTISTRY-7 : phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer

enthalten in: Future oncology (London, England) | 2023

von Herzog, T. | Hays, J. | Barlin, J. | +19

10

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors

enthalten in: Targeted oncology | 2023

von Bauer, T. | Moore, K. | Rader, J. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]